Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples